Ian Colrain talks about SRI Biosciences

The Dish TV series banner

Ian Colrain is the former President of SRI’s Biosciences Division in Menlo Park, CA. Join us to learn how SRI Biosciences partners with organizations worldwide to bring new medicines and devices to market through basic research, pharmaceutical and technology discovery, preclinical development and clinical translation. provides services that span all stages of drug and diagnostics discovery and nonclinical development leading to human clinical trials and, ultimately, to the market. They deliver next-generation drugs, diagnostics and devices to solve unmet medical needs and work with partners to develop transformative approaches and platforms for the toughest therapeutic problems.

Learn more about SRI Biosciences at: https://www.sri.com/biomedical-sciences/

SRI’s The Dish TV highlights the most special part of SRI—our people. Join us for casual conversations with guests from across our institute about what brought them to and keeps them at SRI, as well as the latest world-changing innovations to come out of their groups. At SRI, we’re inventing a better future together.


Read more from SRI

  • surgeons around a surgical robot

    The SRI research behind today’s surgical robotics

    Intuitive’s da Vinci 5 system represents a major leap in robotic-assisted medicine. It all started at SRI, which continues to advance teleoperation technologies.

  • a collage of digital graphs

    A banner year for quantum

    SRI-managed QED-C’s annual report on quantum trends captures an industry accelerating rapidly from technical promise toward major global impact.

  • ICE Cube containing SRI’s aerogel experiment, photographed prior to launch. Source: Aerospace Applications North America

    An SRI carbon capture experiment launches into space

    By synthesizing carbon-absorbing aerogels in microgravity, SRI research will give us a rare glimpse into how these materials could be radically improved.